Chen SL, Feng Y, Xue J, Wang S, Wu SL. Efficacy and Safety of Orelabrutinib for Previously Treated Marginal Zone Lymphoma. J Hematol [Internet]. 2025 Jan. 1 [cited 2026 Jan. 11];14(6):297-306. Available from: https://jh.elmerpub.com/jh/article/view/2149